FINNENCE ▪ THE WIRE FILE
THE WIRE · № 80579
News▼ Bearish
BVXX IPO News - Cardiac medical device developer BioVentrix withdraws $17 million IPO
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZE4 RECORDS
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A withdrawn small IPO signals weak demand for early-stage medtech issuance.
Small-cap medtech IPO demand remains fragile
CATALYST TO WATCH
Other medtech IPO pricing outcomes
MAIN RISK
Single withdrawal may not signal a trend
02 THE STORY SO FAR
THE RECORD, IN ORDER.
UPDATED 4 TIMES · FIRST · LAST2026-10-14 18:33 UTCNewsBVXX IPO News - Cardiac medical device developer BioVentrix withdraws $17 million IPOCURRENT RECORD
2026-10-14 18:33 UTCNewsAtrium-WakeMed merger terms questioned, calls for transparency on the deal increasing
2026-10-14 21:39 UTCNewsAMRO IPO News - Metal powder producer Amaero prices downsized US IPO at $4.25 per share
2026-10-14 23:11 UTCNewsNvidia-Backed AI Drugmaker Iambic Raises $150 Million in US IPO
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Atrium-WakeMed merger terms questioned, calls for transparency on the deal increasing2026-10-14 18:33 UTC
Atrium-WakeMed merger terms questioned, calls for transparency on the deal increasing2026-10-14 18:33 UTC
→CORRELATIONshares Healthcare
Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)2026-10-14 19:02 UTC
Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)2026-10-14 19:02 UTC
→CORRELATIONshares Healthcare
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)2026-10-14 19:22 UTC
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)2026-10-14 19:22 UTC
→CORRELATIONshares Healthcare
Veeva to Host Virtual Investor Day on November 5, 20262026-10-14 20:05 UTC
Veeva to Host Virtual Investor Day on November 5, 20262026-10-14 20:05 UTC
→CORRELATIONshares Healthcare
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
→CORRELATIONshares Healthcare
Trial Demonstrates Feasibility of At-Home Subcutaneous Diuretic Therapy for Heart Failure-Associated Edema2026-10-14 20:30 UTC
Trial Demonstrates Feasibility of At-Home Subcutaneous Diuretic Therapy for Heart Failure-Associated Edema2026-10-14 20:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.